Bruker Corporation

Healthcare · Medical Devices

60.50$ -5.3% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Balance Sheet

Bruker Corporation (BRKR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 6,053 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet BRKR
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	1,798	1,813	1,840	1,913	1,962	1,949	1,831	1,806	1,889	2,129	2,243	2,350	2,352	2,772	2,962	2,943	2,879	3,049	3,035	3,087	3,128	3,650	3,551	3,385	3,337	3,612	3,764	3,857	3,820	4,250	4,506	5,903	6,113	5,807	5,933	6,340	6,435	6,241	6,131	6,053
Current Assets	1,267	1,273	1,264	1,300	1,337	1,359	1,241	1,182	1,262	1,304	1,344	1,406	1,434	1,796	1,990	1,957	1,826	1,925	1,946	1,968	1,989	2,472	2,251	2,088	2,037	2,113	2,133	2,183	2,029	2,164	2,140	2,153	2,191	2,053	2,112	2,163	2,351	2,213	2,104	2,225
Cash	279	342	278	218	264	325	284	259	270	322	299	283	296	678	796	747	567	682	697	608	573	1,068	816	723	626	646	598	575	364	488	340	170	148	183	184	92	293	299	133	185
Cash & Short-Term Investments	442	500	465	440	429	439	284	259	270	322	299	289	302	685	852	797	617	732	747	706	670	1,168	916	723	626	646	598	575	364	488	340	170	148	183	184	92	293	299	133	185
Receivables	224	244	225	240	270	319	314	279	323	357	360	348	359	362	326	325	330	335	326	337	372	417	414	403	421	595	472	602	656	622	636	694	713	701	701	739	767	736	750	875
Inventory	483	440	476	505	515	486	518	509	519	510	542	595	587	577	626	665	696	692	701	730	733	710	740	759	750	800	859	915	916	968	1,061	1,176	1,220	1,068	1,117	1,218	1,197	1,095	1,122	1,120
Property, Plant & Equipment	239	239	241	253	260	267	270	259	261	271	268	282	278	306	319	336	355	396	384	398	389	406	404	395	422	487	511	523	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	131	131	152	165	169	170	171	192	200	276	275	285	282	293	290	295	313	320	313	315	324	340	384	396	382	458	527	558	561	583	752	1,444	1,475	1,507	1,533	1,649	1,550	1,548	1,573	1,430
Intangible Assets	61	70	86	196	364	323	149	172	167	219	279	302	289	233	301	295	325	229	213	206	218	212	228	234	214	271	299	300	292	331	449	1,024	1,027	913	902	970	919	900	902	868
Total Liabilities	1,097	1,120	1,108	1,150	1,222	1,215	1,040	1,021	1,064	1,224	1,321	1,480	1,497	1,833	2,037	2,037	1,917	2,075	2,053	2,071	2,038	2,565	2,513	2,394	2,383	2,480	2,565	2,606	2,575	2,837	3,056	4,078	4,270	3,992	4,082	4,473	3,943	3,731	3,628	3,634
Current Liabilities	553	526	515	494	514	525	559	532	563	598	633	641	643	646	766	750	683	792	944	955	921	939	881	818	865	914	1,049	1,051	1,072	1,202	1,183	1,305	1,322	1,281	1,345	1,347	1,268	1,279	1,355	1,205
Short-Term Debt	20	20	0.1	0.1	481	416	15	15	15	19	2.6	0.3	0.3	21	96	101	1.7	24	108	108	110	130	11	14	17	35	120	121	121	145	21	26	33	65	38	56	24	52	8.4	101
Accounts Payable	93	86	95	92	95	91	105	105	100	105	127	124	117	118	127	119	114	135	152	143	141	147	161	155	158	178	196	189	182	203	199	220	228	234	245	243	184	216	269	200
Long-Term Debt	345	392	385	431	481	416	206	206	225	323	332	494	519	813	915	924	828	842	716	721	718	1,222	1,205	1,171	1,137	1,201	1,109	1,123	1,099	1,160	1,357	2,132	2,265	2,062	2,076	2,380	1,984	1,853	1,663	1,815
Shareholders' Equity	701	693	732	763	740	734	790	785	825	905	922	870	855	907	916	897	952	961	968	1,002	1,076	1,071	1,017	971	937	1,114	1,180	1,231	1,209	1,377	1,415	1,789	1,807	1,781	1,817	1,804	2,432	2,457	2,449	2,400
Retained Earnings	0.0	885	885	0.0	0.0	942	942	0.0	0.0	1,103	1,103	–	1,212	1,275	1,275	–	1,344	1,407	1,457	1,509	1,590	1,660	1,714	57	153	1,926	–	–	–	2,324	2,367	2,367	2,401	2,407	2,416	2,416	2,352	2,362	2,358	2,288
Shares Outstanding	162	161	161	160	159	156	157	157	157	157	158	158	156	155	155	155	154	154	153	153	153	153	151	150	149	148	148	148	147	146	146	148	152	152	152	152	152	153	153	152

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings